Markets
markets

Healthcare stocks sink after Trump admin proposes flat rates for Medicare insurers

Major health insurers and healthcare companies are under pressure in early trading on Tuesday after the Trump administration proposed roughly flat rates for Medicare insurers next year.

The Centers for Medicare and Medicaid Services announced after the bell on Monday that payments to the plan will increase by just 0.09% in 2027, less than the 4% to 6% analysts expected. CMS also plans to crack down on inaccurate overbilling by changing how “risk score,” which pays more for sicker patients, is calculated.

Private Medicare plans, or Medicare Advantage, is a core business for insurers including UnitedHealth, CVS Health, and Humana, which all fell double digits in premarket trading on Tuesday. Even insurers less dependent on Medicare specifically, like Elevance Health, Centene, and Molina Healthcare dropped more than 5%.

Among the healthcare giants, UnitedHealth is the biggest loser this morning, with its shares down 14% after its woes were compounded by a lackluster full-year forecast. The company expects a decline in yearly revenue for 2026 — which would be its first annual revenue decrease in more than three decades. The company has also been under investigation by the Department of Justice for its Medicare billing practices.

The announcement comes after a difficult year for insurers, particularly those that offer government-sponsored plans. Insurers are likely to lobby for higher payments before the rate is finalized in April. If it goes through unchanged, plans will likely slash coverage and raise premiums to protect margins, according to analysts at Deutsche Bank.

“The industry was in the earliest stages of a multi-year margin recovery cycle which will now be in question,” the analysts wrote in a Tuesday morning note.

Private Medicare plans, or Medicare Advantage, is a core business for insurers including UnitedHealth, CVS Health, and Humana, which all fell double digits in premarket trading on Tuesday. Even insurers less dependent on Medicare specifically, like Elevance Health, Centene, and Molina Healthcare dropped more than 5%.

Among the healthcare giants, UnitedHealth is the biggest loser this morning, with its shares down 14% after its woes were compounded by a lackluster full-year forecast. The company expects a decline in yearly revenue for 2026 — which would be its first annual revenue decrease in more than three decades. The company has also been under investigation by the Department of Justice for its Medicare billing practices.

The announcement comes after a difficult year for insurers, particularly those that offer government-sponsored plans. Insurers are likely to lobby for higher payments before the rate is finalized in April. If it goes through unchanged, plans will likely slash coverage and raise premiums to protect margins, according to analysts at Deutsche Bank.

“The industry was in the earliest stages of a multi-year margin recovery cycle which will now be in question,” the analysts wrote in a Tuesday morning note.

More Markets

See all Markets
markets

SpaceX gets a wave of bullish ratings from Wall Street analysts

SpaceX received more than a dozen positive analyst calls on Tuesday — including from major Wall Street banks — as they initiate coverage on Elon Musk’s space and AI company.

SpaceX went public on June 12 at a $2.2 trillion valuation, the largest debut in history. While the company hasn’t yet posted a profit, it seems to have convinced Wall Street that it will get there and grow its valuation on the way.

Of the at least 17 analysts that gave a rating on Tuesday, all but one gave it a “buy” or “outperform” rating. MoffettNathanson was "neutral."

The ratings come as SpaceX joined the Nasdaq 100 index, a benchmark tech-heavy basket of companies that underpins millions of portfolios. The inclusion adds built-in demand for the stock from index funds and ETFs.

Still, SpaceX fell more than 5% on Tuesday amid a broader sell-off, and is currently effectively flat from its opening price of $150 a share.

markets

Nike sinks to lowest level since 2014 after warning of “challenged” sales environment in Q4 report

Did Nike do it?

Investors had a mixed reaction after the global sports apparel company reported its fourth quarter earnings on Tuesday after the bell. Shares initially rose 5% as Nike beat out Wall Street expectations amid a hefty tariff refund bonus. However, the stock then sank to its lowest level since August 2014 in postmarket trading.

Here are the Q4 numbers:

  • Revenue of $11.0 billion (estimate: $10.8 billion).

  • Adjusted earnings per share of $0.20 (estimate: $0.12).

Ahead of this report, Nike warned that results would be flattered by a one-time tariff refund (now estimated at roughly $0.52 per share for the bottom line). That gave the company an extra cushion in snapping its streak of seven quarters of year-over-year profit declines.

Over the past year, the company had been punished by tariffs on imported goods, stagnant consumer spending, and increasing competition from other footwear brands like New Balance, Adidas, and Hoka.

Outgoing CFO Matthew Friend deemed it an “increasingly challenging operating environment, where sell-through remains challenged.”

Latest Stories

Sherwood Media, LLC and Chartr Limited produce fresh and unique perspectives on topical financial news and are fully owned subsidiaries of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, Robinhood Money, LLC, Robinhood U.K. Ltd, Robinhood Derivatives, LLC, Robinhood Gold, LLC, Robinhood Asset Management, LLC, Robinhood Credit, Inc., Robinhood Ventures DE, LLC and, where applicable, its managed investment vehicles.